Business
Executive Chair share purchase
EKF Diagnostics Holdings plc announced that its Executive Chair, Julian Baines, purchased 85,000 ordinary shares at 23.0 pence per share on December 15, 2025. Following this transaction, Mr. Baines now holds 1,751,288 ordinary shares, representing approximately 0.40% of the company's issued share capital. This purchase by a key executive could be viewed positively by the market as a sign of confidence in the company's future prospects. Disclaimer*
About this update from Ekf Diagnostics Holdings Plc
EKF Diagnostics Holdings plc ("EKF" or the "Company") Executive Chair share purchase EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed global diagnostics business, announces that on Monday 15 December, Julain Baines, Executive Chair, purchased a total of 85,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares") at a price of 23.0 pence per Ordinary Share. Following this transaction, Julian Baines' total interest in the Company is 1,751,288 Ordinary Shares, representing approximately 0.40% of the total voting rights over the Company's issued share capital. The Notification of Dealing Form required in accordance with UK MAR is set out below as is the Standard form for notification of major holdings received by EKF today. EKF Diagnostics Holdings plc www.ekfdiagnostics.com Julian Baines, Executive Chair Via Walbrook PR Gavin Jones, Chief Executive Officer Tel: +44 (0)20 7496 3000 Singer Capital Markets (Nominated Adviser & Broker) Phil Davies / Oliver Platts Walbrook PR Limited Tel: +44 (0)20 7933 8780 or [email protected] Paul McManus / Alice Woodings Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654 About EKF Diagnostics Holdings plc ( www.ekfdiagnostics.com ) EKF is an AIM-listed global diagnostics business focussed on: · Point-of-Care analysers in the key areas of Hematology and Diabetes. · Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide. Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 1 Details of the person discharging managerial responsibilities / person closely associated a) Name Julian Baines 2 Reason for the notification a) Position/status Executive Chair b) Initial notification /Amendment Initial Notification 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name EKF Diagnostics Holdings plc b) LEI 213800DXTF3EAUK1AR05 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each Identification code GB0031509804 b) Nature of the transaction Purchase of Ordinary Shares c) Price(s) and volume(s) Price(s) Volume(s) 23p 85,000 d) Aggregated information - Aggregated volume N/A single transaction - Price e) Date of the transaction 15 December 2025 f) Place of the transaction London Stock Exchange, AIMX
View stock analysis, news, and events for Ekf Diagnostics Holdings Plc